Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.064 AUD | +4.92% | +3.23% | -9.86% |
Apr. 04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
Feb. 27 | Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive | MT |
Chart calendar Noxopharm Limited
Upcoming events on Noxopharm Limited
Past events on Noxopharm Limited
2024-03-12 | RNA Leaders Europe Conference |
2024-02-26 04:01 pm | Q2 2024 Earnings Release |
2024-01-21 08:31 pm | December 2023 Sales and Revenue Release - Activities Report |
2023-11-15 09:00 pm | Annual General Meeting |
2023-08-31 12:07 am | Q4 2023 Earnings Release |
2023-07-13 06:19 pm | June 2023 Sales and Revenue Release - Activities Report |
2023-06-01 | American Society of Clinical Oncology Conference |
2023-05-16 | LUPUS International Conference |
2023-02-23 09:24 pm | Q2 2023 Earnings Release |
2023-01-26 | December 2022 Sales and Revenue Release - Activities Report |
2022-11-16 09:00 pm | Annual General Meeting |
2022-08-25 02:32 am | FY 2022 Earnings Release |
2022-07-26 | June 2022 Sales and Revenue Release - Activities Report |
2022-02-20 | Interim 2022 Earnings Release |
2022-01-26 | December 2021 Sales and Revenue Release - Activities Report |
2022-01-09 | H.C. Wainwright BioConnect Conference |
2021-11-16 09:00 pm | Annual General Meeting |
2021-09-12 07:00 pm | H.C. Wainwright Global Investment Conference |
2021-08-25 | FY 2021 Earnings Release |
2021-08-17 07:00 pm | Inaugural Prostate Cancer Drug Development Summit |
Past sector events for Noxopharm Limited
- Stock Market
- Equities
- NOX Stock
- Calendar Noxopharm Limited